X0206 3 2020-12-02 0 0001797768 Kinnate Biopharma Inc. KNTE 0001579310 Flaherty Keith T. 11975 EL CAMINO REAL, SUITE 101 SAN DIEGO CA 91230 true Common Stock 66377 D Stock Option (Right to Buy) 0.18 2028-09-17 Common Stock 32064 D Stock Option (Right to Buy) 2.57 2030-02-05 Common Stock 56112 D Stock Option (Right to Buy) 5.63 2030-08-18 Common Stock 11391 D The Option vests and becomes exercisable over time at the following rate: 1/48th of the total number of shares subject to the Option shall vest monthly in equal installments over four years commencing on the one-month anniversary of June 1, 2018, the Vesting Commencement Date, and each month thereafter on the same day of the month as the Vesting Commencement Date. The Option vests and becomes exercisable over time at the following rate: 1/48th of the total number of shares subject to the Option shall vest monthly in equal installments over four years commencing on the one-month anniversary of December 19, 2019, the Vesting Commencement Date, and each month thereafter on the same day of the month as the Vesting Commencement Date. The Option vests and becomes exercisable over time at the following rate: 1/48th of the total number of shares subject to the Option shall vest monthly in equal installments over four years commencing on the one-month anniversary of August 1, 2020, the Vesting Commencement Date, and each month thereafter on the same day of the month as the Vesting Commencement Date. Date set forth above represents the effective date of the issuer's initial public offering. Exhibit List: Exhibit 24 - Power of Attorney /s/ Mark A. Meltz, attorney-in-fact 2020-12-02